Nurix Therapeutics Inc. Common stock (NRIX) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Nurix Therapeutics Inc. Common stock, updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$27.26
+2.10% today
Market cap
$2.9B
Overall quality
—
Kronos AI 30-day
−15.2%
0 of 8 simulated paths end higher
Nurix Therapeutics Inc. Common stock (NRIX) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $2.9B. It trades at $27.26, up 2.10% today. 10 analysts' average target of $34.50 implies +26.6% from today's price. Kronos AI's 30-day forecast is −15.2% (0 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $34.50 |
| Low – high | $25.00 – $41.00 |
| Analysts | 10 |
| Upside to average | +26.6% |
Kronos AI 30-day forecast
| Expected close | $22.64 (−15.2%) |
| Likely range | −20.8% … −8.6% |
| As of | 2026-10-27 |
0 of 8 simulated paths end higher.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.